BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6666830)

  • 1. [Amniotic fluid proteinogram in normal pregnancy and in late pregnancy toxemias].
    Strizhova NV; Petrunina IuA; Zlatovratskaia TV
    Akush Ginekol (Mosk); 1983 Dec; (12):8-9. PubMed ID: 6666830
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunoglobulins in the amniotic fluid of women with late pregnancy toxicoses].
    Karadzhova R; Georgiev G; Kiutukchiev B
    Akush Ginekol (Sofiia); 1985; 24(6):9-12. PubMed ID: 3937458
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination of immunoglobulins and complement in pregnancy toxemias].
    Buitrón García RG; Cueva Velázquez J; Orea Solano M; Sánchez Rangel P; Meza F
    Alergia; 1983 Oct; 30(4):159-66. PubMed ID: 6670722
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of the amniotic fluid in changes of immunologic homeostasis in normal pregnancy and late pregnancy toxemia].
    Zhuchenko PG; Lozhkareva VA; Lutsiuk NB
    Akush Ginekol (Mosk); 1986 Apr; (4):49-51. PubMed ID: 2940922
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunological study in pre-eclampsia].
    Astorga G; Aguirre H; Rencoret R
    Rev Med Chil; 1973 Jul; 101(7):534-8. PubMed ID: 4769460
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoglobulin and C3 levels in normal human amniotic fluid.
    Sharma A; Prabhakar P; Sharma DP; Jayasinghe RG
    West Indian Med J; 1983 Sep; 32(3):140-6. PubMed ID: 6636716
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of some indices of immunity in amniotic fluid (author's transl)].
    Mosnová H; Král J; Tomásová H; Barnová M
    Cesk Epidemiol Mikrobiol Imunol; 1980 Dec; 29(6):367-73. PubMed ID: 6450645
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M; Bengtson A; Karlsson K; Heideman M
    Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The significant of complement and immunoglobulin determination in healthy pregnant women and patients with EPH gestoses.
    Rosić B; Sulović V; Juznić N; Lazarević B; Vidanović M
    Clin Exp Obstet Gynecol; 1988; 15(4):157-60. PubMed ID: 3233758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunological properties of the amniotic fluid in physiological pregnancy and gestoses].
    Starostina TA; Kudriashova NM; Belokrinitskiĭ DV; Razmakhnina NI; Seredina TA
    Akush Ginekol (Mosk); 1991 Dec; (12):10-2. PubMed ID: 1789334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serial complement (C3 and CH 50) and immunoglobulin levels in toxaemic pregnancy (author's transl)].
    Koslowski JP; Guiguet M; Taquoi G; Jahier J; Feldman JP; Mavel A; Gallánd JP
    J Gynecol Obstet Biol Reprod (Paris); 1978; 7(5):923-31. PubMed ID: 739123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes of serum protein and immunoglobulin in toxemia of pregnancy.
    Hung TC; Chang CC; Hsu CT; Chuang CY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1980 Jun; 13(2):143-8. PubMed ID: 7449530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes of some immunologic parameters in endangered pregnancy (author's transl)].
    Fuchs V; Vacková L; Kotásek A; Rozprimová L
    Cesk Gynekol; 1980 Feb; 45(1):3-9. PubMed ID: 6966538
    [No Abstract]   [Full Text] [Related]  

  • 14. Pregnancy-associated plasma protein levels at term in normal pregnancy, preeclampsia and essential hypertension.
    Griffin JF
    Aust N Z J Obstet Gynaecol; 1983 Feb; 23(1):11-4. PubMed ID: 6575751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the C3 component of the complement system in the amniotic fluid in normal pregnancy and pregnancy complicated by Rh serologic incompatibility].
    Zalewski J; Pieńkowski W; Gabryś M; Riess A; Zasławski R
    Ginekol Pol; 1986 Oct; 57(10):650-3. PubMed ID: 3102320
    [No Abstract]   [Full Text] [Related]  

  • 16. Pregnancy-specific beta 1-glycoprotein in amniotic fluid in high risk late pregnancy.
    Heikinheimo M
    Oncodev Biol Med; 1980; 1(4-5):287-90. PubMed ID: 6974344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum complement in normal pregnancy and pre-eclampsia.
    Kitzmiller JL; Stoneburner L; Yelenosky PF; Lucas WE
    Am J Obstet Gynecol; 1973 Oct; 117(3):312-5. PubMed ID: 4199698
    [No Abstract]   [Full Text] [Related]  

  • 18. [Circulating immune complexes and immunoglobulins A, M and G in the mother-fetus system in normal pregnancy and gestosis].
    Starostina TA; Belokrinitskiĭ DV; Kudriashova NM; Razmakhnina NI; Goloshchapova OV; Seredina TA
    Akush Ginekol (Mosk); 1992 Jan; (1):19-22. PubMed ID: 1621904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of late pregnancy toxemias on various immunological indicators in newborn infants].
    Mikhaĭlova ZM; V'iaskova MG
    Vopr Okhr Materin Det; 1979 Jan; 24(1):36-40. PubMed ID: 433189
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quantitative behavior of pregnancy-specific beta glycoproteins (Sp1) in the amniotic fluid in normal and pathologic pregnancies].
    Straube W; Jahns E; Leisner J; Briese V
    Zentralbl Gynakol; 1983; 105(5):270-8. PubMed ID: 6602439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.